Across the globe, heat waves are becoming more frequent and more intense. Therefore, how to effectively combat the adverse effects of heat is an increasingly important topic of research.
FDA OKs Second Gene Therapy for Hemophilia B
The FDA has approved a second gene therapy for adults with hemophilia B, drugmaker Pfizer announced on Friday. The approval of fidanacogene elaparvovec (Beqvez) stipulates
April 27, 2024